BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23473693)

  • 1. Place of proton radiotherapy in future radiotherapy practice.
    Zips D; Baumann M
    Semin Radiat Oncol; 2013 Apr; 23(2):149-53. PubMed ID: 23473693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physics controversies in proton therapy.
    Engelsman M; Schwarz M; Dong L
    Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical controversies: proton therapy for thoracic tumors.
    De Ruysscher D; Chang JY
    Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-beam therapy for tumors of the CNS.
    Gridley DS; Grover RS; Loredo LN; Wroe AJ; Slater JD
    Expert Rev Neurother; 2010 Feb; 10(2):319-30. PubMed ID: 20136386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical controversies: proton therapy for pediatric tumors.
    Merchant TE
    Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological, physical factors in clinical assessment of outcome of cancer therapy.
    Perez CA
    Rays; 2005; 30(2):85-98. PubMed ID: 16294900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of technology to optimize the delivery of proton therapy: the third generation.
    Flanz J; Bortfeld T
    Semin Radiat Oncol; 2013 Apr; 23(2):142-8. PubMed ID: 23473692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of patients potentially eligible for proton therapy.
    Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
    Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of radiation oncology: known and unknown.
    Liu J; Yu J
    Chin Med J (Engl); 2014; 127(11):2173-9. PubMed ID: 24890173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Technological Improvements Reduce the Cost of Proton Radiation Therapy?
    Schippers JM; Lomax A; Garonna A; Parodi K
    Semin Radiat Oncol; 2018 Apr; 28(2):150-159. PubMed ID: 29735191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complications from low-dose proton therapy.
    Mahajan A
    Health Phys; 2012 Nov; 103(5):586-9. PubMed ID: 23032888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton therapy: clinical gains through current and future treatment programs.
    Mohan R; Bortfeld T
    Front Radiat Ther Oncol; 2011; 43():440-464. PubMed ID: 21625168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.